PATENT CLAIM ANALYSIS

Application Number: 15960069
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["544", "280000"]

Abstract:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

Claim (Index 93):
The method of  claim 91 , wherein the cutaneous T-cell lymphoma is mycosis fungoides.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.5641
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13076176', '15233652', '15356957', '14033039', '12549170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.740417492303907
- 35 USC 102 Novelty (BERT): 0.5499901815312154
- Combined Prediction Score: 0.7213747612266379
- Mean Citation Score: 428.34632
- Max Citation Score: 437.2334
- Similarity Product: 253.15764177039864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test